Extracorporeal life support：progress and prospects in 2024

doi:10.3877/cma.j.issn.2096-1537.2025.02.004

Abstract

Abstract:

This article reviews the key research advances in the field of extracorporeal life support in 2024，with a primary focus on patient selection，optimization of management strategies，complication prevention，and technological innovation across multiple dimensions.Numerous research findings have provided clinical practitioners with more precise and cautious guidance for treatment decision-making，while also pointing to new directions for future studies in personalized therapy，multidisciplinary collaboration，and technological innovation.

Key words: Extracorporeal life support, Patient selection, Management strategies, Complication prevention, Technological innovation

Xiaotong Hou, Liangshan Wang, Kexin Wang. Extracorporeal life support：progress and prospects in 2024[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2025, 11(02): 125-129.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2025.02.004

https://icu.cma-cmc.com.cn/EN/Y2025/V11/I02/125

Figures/Tables 1

References 26

1	Ostadal P，Rokyta R，Karasek J，et al.Extracorporeal membrane oxygenation in the therapy of cardiogenic shock：1-year outcomes of the multicentre，randomized ECMO-CS trial ［J］.Eur J Heart Fail，2025，27（1）：30-36.
2	Desch S，Zeymer U，Akin I，et al.Routine extracorporeal life support in infarct-related cardiogenic shock：1-year results of the ECLSSHOCK trial ［J］.Eur Heart J，2024，45（39）：4200-4203.
3	Low C，Ling RR，Ramanathan K，et al.Extracorporeal cardiopulmonary resuscitation versus conventional CPR in cardiac arrest：an updated meta-analysis and trial sequential analysis ［J］.Crit Care，2024，28（1）：57.
4	Scquizzato T，Calabrò MG，Franco A，et al.Extracorporeal cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest：10-year experience in a metropolitan cardiac arrest centre in Milan，Italy ［J］.Resusc Plus，2024，17：100521.
5	Viersen VA，Greuters S，Korfage AR，et al.Hyperfibrinolysis in out of hospital cardiac arrest is associated with markers of hypoperfusion ［J］.Resuscitation，2012，83（12）：1451-1455.
6	Wada T，Gando S，Ono Y，et al.Disseminated intravascular coagulation with the fibrinolytic phenotype predicts the outcome of patients with out-of-hospital cardiac arrest ［J］.Thromb J，2016，14：43.
7	Magomedov A，Kruse JM，Zickler D，et al.Association of hyperfibrinolysis with poor prognosis in refractory circulatory arrest：implications for extracorporeal cardiopulmonary resuscitation ［J］.Br J Anaesth，2024，133（3）：500-507.
8	Fu HY，Chen YS，Yu HY，et al.Emergent coronary revascularization with percutaneous coronary intervention and coronary artery bypass grafting in patients receiving extracorporeal cardiopulmonary resuscitation ［J］.Eur J Cardiothorac Surg，2024，66（2）：ezae290.
9	Ezad SM，Ryan M，Barrett N，et al.Left ventricular unloading in patients supported with veno-arterial extra corporeal membrane oxygenation； an international EuroELSO survey ［J］.Perfusion，2024，39（1_suppl）：13S-22S.
10	Zhang H，Wang T，Wang J，et al.Different strategies in left ventricle unloading during venoarterial extracorporeal membrane oxygenation：a network meta-analysis ［J］.Int J Cardiol Heart Vasc，2024，54：101506.
11	Inglis SS，Rosenbaum AN，Rizzo SA，et al.Novel left ventricular unloading strategies in patients on peripheral venoarterial extracorporeal membrane oxygenation support ［J］.ASAIO J，2024，70（5）：396-403.
12	Lüsebrink E，Binzenhöfer L，Hering D，et al.Scrutinizing the role of venoarterial extracorporeal membrane oxygenation：has clinical practice outpaced the evidence? ［J］.Circulation，2024，149（13）：1033-1052.
13	Wang K，Wang L，Ma J，et al.Intra-aortic balloon pump after VAECMO reduces mortality in patients with cardiogenic shock：an analysis of the Chinese Extracorporeal Life Support Registry ［J］.Crit Care，2024，28（1）：394.
14	Premraj L，Brown A，Fraser JF，et al.Oxygenation during venoarterial extracorporeal membrane oxygenation：physiology，current evidence，and a pragmatic approach to oxygen titration ［J］.Crit Care Med，2024，52（4）：637-648.
15	Burrell A，Bailey MJ，Bellomo R，et al.Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation ［J］.Intensive Care Med，2024，50（9）：1470-1483.
16	Chandel A，Fabyan KD，Mendelsohn S，et al.Prevalence and survival of prolonged venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome：an analysis of the Extracorporeal Life Support Organization Registry ［J］.Crit Care Med，2024，52（6）：869-877.
17	Bunge J，Mariani S，Meuwese C，et al.Characteristics and outcomes of prolonged venoarterial extracorporeal membrane oxygenation after cardiac surgery：the post-cardiotomy extracorporeal life support（PELS-1） cohort study ［J］.Crit Care Med，2024，52（10）：e490-e502.
18	Martucci G，Giani M，Schmidt M，et al.Anticoagulation and bleeding during veno-venous extracorporeal membrane oxygenation：insights from the PROTECMO study ［J］.Am J Respir Crit Care Med，2024，209（4）：417-426.
19	Mansour A，Berahou M，Odot J，et al.Antithrombin levels and heparin responsiveness during venoarterial extracorporeal membrane oxygenation：a prospective single-center cohort study ［J］.Anesthesiology，2024，140（6）：1153-1164.
20	Xu P，Zhang Y，Guo J，et al.A single-domain antibody targeting factorⅫ inhibits both thrombosis and inflammation ［J］.Nat Commun，2024，15（1）：7898.
21	中国医师协会体外生命支持专业委员会.体外膜氧合患者脑监测中国专家共识［J］.中华医学杂志，2024，104（9）：662-673.
22	Cho SM，Hwang J，Chiarini G，et al.Neurological monitoring and management for adult extracorporeal membrane oxygenation patients：Extracorporeal Life Support Organization consensus guidelines ［J］.Crit Care，2024，28（1）：296.
23	Cho SM，Khanduja S，Wilcox C，et al.Clinical use of bedside portable ultra-low-field brain magnetic resonance imaging in patients on extracorporeal membrane oxygenation：results from the multicenter SAFE MRI ECMO study ［J］.Circulation，2024，150（24）：1955-1965.
24	Haus M，Foltan M，Philipp A，et al.Neutrophil extracellular traps -a potential trigger for the development of thrombocytopenia during extracorporeal membrane oxygenation ［J］.Front Immunol，2024，15：1339235.
25	Swain L，Bhave S，Qiao X，et al.Novel role for cardiolipin as a target of therapy to mitigate myocardial injury caused by venoarterial extracorporeal membrane oxygenation ［J］.Circulation，2024，149（17）：1341-1353.
26	Goh T，Gao L，Singh J，et al.Platelet adhesion and activation in an ECMO thrombosis-on-a-chip model ［J］.Adv Sci （Weinh），2024，11（30）：e2401524.

研究名称	研究类型	干预措施	主要结局	关键发现
ECMO-CS^[1]	多中心随机对照试验	立即 ECMO 组（58 例），早期保守策略组（59 例）	1 年全因病死率	立即 ECMO 组和早期保守策略组无显著差异
ECLS-SHOCK^[2]	多中心随机对照试验	ECMO 组（209 例），对照组（208 例）	1 年全因病死率	ECMO 组和对照组无显著差异

研究名称	研究类型	干预措施	主要结局	关键发现
ECMO-CS^[1]	多中心随机对照试验	立即 ECMO 组（58 例），早期保守策略组（59 例）	1 年全因病死率	立即 ECMO 组和早期保守策略组无显著差异
ECLS-SHOCK^[2]	多中心随机对照试验	ECMO 组（209 例），对照组（208 例）	1 年全因病死率	ECMO 组和对照组无显著差异

[1]	Xiaotao Liu, Xuepeng Li, Bo Yang, Jianrong Li, Zhenfeng Xue. Analysis of reasons for same-day cancellations of day surgery in general hospital and the application effect of refined management [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2025, 19(02): 219-223.
[2]	Hao Xu, Liang Luo. Research progress in hospital acquired infections of ECMO patients [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(03): 292-297.
[3]	Wenzhe Li, Pengfei Pan, Jian Cui, Xiangyou Yu. Ethical issues in the clinical application of extracorporeal life support [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(02): 97-101.
[4]	Yunhe Hu, Yuzhuo Zhou, Ruiying Fu, Fan Yu, Aidong Li. Influencing factors and management strategies for GB1 group hospitalization expenses under the CHS-DRG payment system [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(06): 568-574.

Please choose a citation manager

Content to export